---
category: listing
circular_id: eb679bee76d77f96
date: '2025-12-23'
description: Trading approval for 24,42,000 equity shares of Shelter Pharma Limited
  issued on preferential basis at Rs. 42.25 per share with lock-in periods until June
  2026 and June 2027.
draft: false
guid: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={0E454ADD-819B-4FCB-B343-C0E731365990}&noticeno=20251223-10&dt=12/23/2025&icount=10&totcount=24&flag=0
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine listing of preferential allotment shares with standard lock-in
  requirements. Limited market impact as shares are locked in.
pdf_url: https://www.bseindia.com/markets/MarketInfo/DownloadAttach.aspx?id=20251223-10&attachedId=25c06983-b36b-4210-ba75-fefd170035a9
processing:
  attempts: 1
  content_hash: 1251dc230d06a4fe
  processed_at: '2025-12-23T12:52:07.715987'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-12-23T10:32:43+00:00'
rss_url: https://www.bseindia.com/markets/MarketInfo/DispNoticesNCirculars.aspx?Noticeid={0E454ADD-819B-4FCB-B343-C0E731365990}&noticeno=20251223-10&dt=12/23/2025&icount=10&totcount=24&flag=0
severity: low
source: bse
stocks:
- SHELTERPHARMA
tags:
- listing
- preferential-allotment
- equity-shares
- lock-in
- new-securities
title: Listing of New Securities of Shelter Pharma Limited - Preferential Allotment
---

## Summary

Shelter Pharma Limited has applied for trading of 24,42,000 equity shares of face value Rs. 10/- per share issued on preferential basis at Rs. 42.25 per share (including premium of Rs. 32.25 per share). The shares were allotted in two tranches on October 1, 2025 and October 3, 2025, with lock-in periods extending until June 2026 and June 2027.

## Key Points

- Total shares issued: 24,42,000 equity shares
- Face value: Rs. 10/- per share
- Issue price: Rs. 42.25 per share (premium of Rs. 32.25)
- Allotment dates: October 1, 2025 and October 3, 2025
- Distinctive numbers range: 1,15,59,793 to 1,40,01,792
- Lock-in dates: June 29-30, 2026 and June 30, 2027
- Managing Director: Mustaqim Nisarahmed Sabugar (DIN: 01456841)

## Regulatory Changes

No regulatory changes announced.

## Compliance Requirements

- Allottees must comply with lock-in period requirements
- Shares allotted on October 1, 2025: Lock-in until June 29-30, 2026
- Shares allotted on October 3, 2025: Lock-in until June 30, 2026 and June 30, 2027

## Important Dates

- **Allotment Date 1**: October 1, 2025
- **Allotment Date 2**: October 3, 2025
- **Lock-in Expiry (Tranche 1)**: June 29-30, 2026
- **Lock-in Expiry (Tranche 2)**: June 30, 2026 and June 30, 2027

## Impact Assessment

Minimal immediate market impact as all preferentially allotted shares are subject to lock-in periods. The shares cannot be traded until their respective lock-in dates expire. This is a standard listing process for preferential allotment with appropriate investor protections through staggered lock-in requirements.